Clinical trials
Phase 3 Coronary Artery Disease trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 3 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 6 |
| 2014 | 3 |
| 2015 | 3 |
| 2018 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Active, not recruiting | 4 |
| Terminated | 4 |
| Unknown status | 2 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 3 |
| Novartis Pharmaceuticals | 3 |
| Ottawa Heart Institute Research Corporation | 3 |
| Bayer | 2 |
| Boston Scientific Corporation | 2 |
| Bracco Diagnostics, Inc | 2 |
| Hamilton Health Sciences Corporation | 2 |
| Montreal Heart Institute | 2 |
| Sunnybrook Health Sciences Centre | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 47 |
| Myocardial Infarction | 7 |
| Heart Diseases | 5 |
| Acute Coronary Syndrome | 4 |
| Cardiovascular Diseases | 4 |
| Stroke | 4 |
| Angina Pectoris | 3 |
| Atherosclerosis | 3 |
| Coronary Disease | 3 |
| Heart Failure | 3 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.